ATE536101T1 - Behandlung heilmittelresistenter proliferativer erkrankungen - Google Patents

Behandlung heilmittelresistenter proliferativer erkrankungen

Info

Publication number
ATE536101T1
ATE536101T1 AT06717284T AT06717284T ATE536101T1 AT E536101 T1 ATE536101 T1 AT E536101T1 AT 06717284 T AT06717284 T AT 06717284T AT 06717284 T AT06717284 T AT 06717284T AT E536101 T1 ATE536101 T1 AT E536101T1
Authority
AT
Austria
Prior art keywords
treatment
drug
proliferative diseases
resistant
resistant proliferative
Prior art date
Application number
AT06717284T
Other languages
English (en)
Inventor
M V Ramana Reddy
E Premkumar Reddy
Stephen Cosenza
Stacey Baker
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Application granted granted Critical
Publication of ATE536101T1 publication Critical patent/ATE536101T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT06717284T 2005-01-05 2006-01-04 Behandlung heilmittelresistenter proliferativer erkrankungen ATE536101T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64137805P 2005-01-05 2005-01-05
PCT/US2006/000059 WO2006074149A2 (en) 2005-01-05 2006-01-04 Treatment of drug-resistant proliferative disorders

Publications (1)

Publication Number Publication Date
ATE536101T1 true ATE536101T1 (de) 2011-12-15

Family

ID=36648100

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06717284T ATE536101T1 (de) 2005-01-05 2006-01-04 Behandlung heilmittelresistenter proliferativer erkrankungen

Country Status (9)

Country Link
US (1) US20090306207A1 (de)
EP (1) EP1841420B1 (de)
JP (1) JP5156389B2 (de)
KR (2) KR101427105B1 (de)
AT (1) ATE536101T1 (de)
AU (1) AU2006204103B2 (de)
CA (1) CA2593523C (de)
IL (1) IL184292A (de)
WO (1) WO2006074149A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2372975T3 (es) * 2005-12-01 2012-01-30 Bristol-Myers Squibb Company Procedimientos de identificación y tratamiento de individuos que muestran cariotipos.
WO2009128805A1 (en) * 2008-04-17 2009-10-22 The Johns Hopkins University On01910. na enhances chemotherapeutic agent activity in drug-resistant tumors
CN110776447A (zh) 2012-09-20 2020-02-11 坦普尔大学 取代的烷基二芳基衍生物、制备方法和用途
WO2017023912A1 (en) 2015-08-03 2017-02-09 Temple University - Of The Commonwealth System Of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use
CN111926086B (zh) * 2020-08-21 2022-05-31 云南农业大学 一种影响鸡体斜长的分子标记及其应用
CA3228644A1 (en) * 2021-08-12 2023-02-16 Onconova Therapeutics, Inc. Methods and compositions for treating cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2210601C2 (ru) * 1996-07-25 2003-08-20 Ипкор Н.В. Способ восстановления и плавления металла
CZ299718B6 (cs) * 1997-10-03 2008-10-29 Temple University - Of The Commonwealth System Ofhigher Education Styrylsulfonová sloucenina a farmaceutický prostredek ji obsahující
US6548553B2 (en) 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
EP1173160B1 (de) * 1999-04-02 2005-06-22 Temple University of the Commonwealth System of Higher Education (e)-styrylsulfone als krebsbestreitende mittel
US6762207B1 (en) * 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
US6243322B1 (en) * 1999-11-05 2001-06-05 Wavemakers Research, Inc. Method for estimating the distance of an acoustic signal
US6541475B2 (en) * 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
US6486210B2 (en) * 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
JP4302986B2 (ja) * 2001-02-28 2009-07-29 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 細胞及び組織をα，β不飽和アリールスルホンにより電離放射線から防護する方法
IL163608A0 (en) * 2002-02-28 2005-12-18 Univ Temple Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
IL163607A0 (en) * 2002-02-28 2005-12-18 Univ Temple Amino-substituted 2,6-dialkoxystyryl 4-substitutedbenzylsulfones for treating proliferative disorders
WO2005046599A2 (en) * 2003-11-14 2005-05-26 Temple University - Of The Commonwealth System Of Higher Education Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
EA200901236A1 (ru) * 2004-03-16 2009-12-30 Темпл Юниверсити - Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Замещённые фенокси- и фенилтиопроизводные для лечения пролиферативных нарушений

Also Published As

Publication number Publication date
AU2006204103A1 (en) 2006-07-13
WO2006074149A2 (en) 2006-07-13
EP1841420A4 (de) 2009-12-09
IL184292A0 (en) 2007-10-31
WO2006074149A3 (en) 2007-11-15
KR20070094956A (ko) 2007-09-27
KR20130091796A (ko) 2013-08-19
AU2006204103B2 (en) 2011-11-24
EP1841420A2 (de) 2007-10-10
CA2593523C (en) 2014-04-08
JP5156389B2 (ja) 2013-03-06
JP2008526852A (ja) 2008-07-24
KR101427105B1 (ko) 2014-08-07
EP1841420B1 (de) 2011-12-07
IL184292A (en) 2012-10-31
US20090306207A1 (en) 2009-12-10
CA2593523A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
EA202092899A1 (ru) Гетероарильные соединения для лечения болезни гентингтона
CY1112429T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
ECSP099414A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
CR10072A (es) Derivados de pirimidinil-aril-urea que son inhibidores de fgf
EA200801362A1 (ru) Пиримидинил бензотиофеновые соединения
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
DK1625126T3 (da) Imidazo- og thiazolopyridiner som JAK3-kinaseinhibitorer
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
EA200700489A1 (ru) Новые бензоконденсированные гетероарилсульфамидные производные, полезные в качестве противоконвульсивных средств
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200970156A1 (ru) Пиридизиноновые производные
EA201100447A1 (ru) Органические соединения
RS50720B (sr) 3,11 b-cis-dihidrotetrabenazin za lečenje proliferativne bolesti ili inflamacije
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
NO20092130L (no) Tricykliske heteroarylforbindelser anvendelige som inhibitorer of januskinase
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
MA32505B1 (fr) 5-alcynyl-pyrimidines
EA200971141A1 (ru) Соединения, активирующие теломеразу, и способы их применения
CO6630193A2 (es) Inhibidores de la actividad de la proteína tirosina quinasa seleccionada
EA200602281A1 (ru) Гетероарилсульфоны и сульфонамиды и их терапевтические применения